Would you use immune checkpoint inhibitors in patients with well-compensated liver cirrhosis?

There are essentially no good data describing the safety and efficacy of immune checkpoint inhibitors in patients with compromised organ function. The issue is complex, in that altered liver function will change protein binding of the drugs, potentially alter catabolism etc. Autoimmune hepatitis has...